Menu

Rallybio Corporation RLYB

Full chart Compare
Set alert

Price alert · RLYB

All alert types
15.66 USD -0.09 (-0.57%)

At closeNov 9, 2026, 4:00 PM EST

15.66 0.00 0.00%

After hours · Nov 9, 4:00 PM ET

15.53 Day range 16.00
3.67 52-week range 17.57
YTD
+185.25%
1 year
+213.20%

Revenue & Expenses

Other Income → Expenses: $24.09MExpenses → Selling, General & Admin: $14.32MExpenses → Research & Development: $19.60MGross Profit → Expenses: $858.00KRevenue → Gross Profit: $858.00KNet Loss → Expenses: $8.98MOther Income$24.09MGross Profit$858.00KNet Loss$8.98MExpenses$33.92MSelling, General & Admin$14.32MResearch & Development$19.60MRevenue$858.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

RLYB annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
858.00K636.00K000
858.00K636.00K000
-33.06M-60.50M-78.93M-67.88M-45.65M
-8.98M-57.77M-74.56M-66.65M-47.01M
-1.59-10.61-14.70-16.70-14.70
RLYB annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
31.37M13.90M24.49M56.96M175.33M
62.26M68.11M115.62M180.44M182.19M
4.30M6.45M9.44M11.12M6.58M
176.00K154.00K392.00K555.00K0
57.96M61.65M106.18M169.32M175.60M
RLYB annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-29.81M-49.28M-60.27M-57.28M-45.53M
47.27M33.49M27.66M-112.17M-2.33M
16.00K5.20M143.00K51.08M82.97M
17.47M-10.59M-32.46M-118.38M35.10M